Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.300 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2002 | 2002 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 1999 | 2007 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.510 | None | 1.000 | 0 | 0 | 2005 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2015 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 1997 | 2017 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
group | 0.700 | None | 0.929 | 1 | 0 | 1993 | 2015 | ||||||||
|
C-X-C motif chemokine receptor 3 | 0.436 | 0.808 | 0.18 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2008 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.200 | None | 0 | 0 | |||||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
desmin | 0.460 | 0.846 | 8.8E-03 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
MDM4 regulator of p53 | 0.461 | 0.808 | 1.00 |
|
group | 0.200 | None | 0 | 0 |